1. DOP26 COVID-19 vaccine effectiveness in Inflammatory Bowel Disease patients on tumor-necrosis factor inhibitors: Real world data from a mass-vaccination campaign. (21st January 2022) Authors: Lev Zion, R; Focht, G; Lujan, R; Mendelovici, A; Friss, C; Greenfeld, S; Kariv, R; Ben-Tov, A; Matz, E; Nevo, D; Barak-Corren, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP50 Recommencement of Inflammatory Bowel Disease medications following colectomy for Ulcerative Colitis. (27th May 2021) Authors: Ledder, O; Lujan, R; Orlanski-Meyer, E; Friss, C; Loewenberg Weisband, Y; Greenfeld, S; Kariv, R; Lederman, N; Matz, E; Focht, G; Yanai, H; Ollech, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP58 predictors of complicated disease course in CD in an administrative database: a nationwide study from the epi-IIRN. (30th January 2023) Authors: Lujan, R; Atia, O; Gili, F; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Lederman, N; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP61 Ethnic disparities in the management of Inflammatory Bowel Disease in Israel and impact on outcomes. (30th January 2023) Authors: Boaz, E; Ledder, O; Dagan, A; Lujan, R; Koslowsky, B; Friss, C; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Lederman, N; Matz, E; Dotan, I; Yellinek, S; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP12 Does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN. (30th January 2023) Authors: Focht, G; Lujan, R; Atia, O; Greenfeld, S; Kariv, R; Loewenberg Weisband, Y; Lederman, N; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP34 Enteral Nutrition Compared with Steroids in Children with Crohn's Disease – In Israel: a nationwide study from the epi-IIRN. (30th January 2023) Authors: Plotkin, L; Lujan, R; Focht, G; Greenfeld, S; Loewenberg Weisband, Y; Lederman, N; Matz, E; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P244 COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based study. (21st January 2022) Authors: Lev Zion, R; Focht, G; Lujan, R; Mendelovici, A; Friss, C; Greenfeld, S; Kariv, R; Ben-Tov, A; Matz, E; Nevo, D; Barak-Corren, Y; Dotan, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P292 Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN). (30th January 2023) Authors: Ben Hur, D; Lebedenko, B; Issaschar, G; Moshe, R; Lujan, R; Focht, G; Loewenberg Weisband, Y; Kariv, R; Ledderman, N; Matz, E; Dotan, I; Turner, D; Pinto, G; Waterman, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P674 Predictors of response to biologics in Crohn's Diseases: A population-based study from the epi-IIRN. (21st January 2022) Authors: Atia, O; Lujan, R; Greenfeld, S; Kariv, R; Matz, E; Dotan, I; Nevo, D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P682 Predictors of response to biologics in Ulcerative Colitis: A population-based study from the epi-IIRN. (21st January 2022) Authors: Atia, O; Lujan, R; Greenfeld, S; Kariv, R; Matz, E; Dotan, I; Nevo, D; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗